Contineum Therapeutics, Inc. Class A Common Stock Dividends
The next dividend date for Contineum Therapeutics, Inc. Class A Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
More About Contineum Therapeutics, Inc. Class A Common Stock
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
Owning Contineum Therapeutics, Inc. Class A Common Stock Stock on the Dividend Date
If you own Contineum Therapeutics, Inc. Class A Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Contineum Therapeutics, Inc. Class A Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Contineum Therapeutics, Inc. Class A Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Contineum Therapeutics, Inc. Class A Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Contineum Therapeutics, Inc. Class A Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Contineum Therapeutics, Inc. Class A Common Stock Dividends
You can contact us any time if you would like to ask questions about Contineum Therapeutics, Inc. Class A Common Stock dividends or anything else related to the stock market.